Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

A clinical evaluation of two central venous catheter stabilization systems.

Karpanen TJ, Casey AL, Whitehouse T, Timsit JF, Mimoz O, Palomar M, Elliott TSJ.

Ann Intensive Care. 2019 Apr 17;9(1):49. doi: 10.1186/s13613-019-0519-6.

2.

A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Timsit JF, Rupp M, Bouza E, Chopra V, Kärpänen T, Laupland K, Lisboa T, Mermel L, Mimoz O, Parienti JJ, Poulakou G, Souweine B, Zingg W.

Intensive Care Med. 2018 Jun;44(6):742-759. doi: 10.1007/s00134-018-5212-y. Epub 2018 May 12. Review.

PMID:
29754308
3.

An in vitro comparison of standard cleaning to a continuous passive disinfection cap for the decontamination of needle-free connectors.

Casey AL, Karpanen TJ, Nightingale P, Elliott TSJ.

Antimicrob Resist Infect Control. 2018 Apr 5;7:50. doi: 10.1186/s13756-018-0342-0. eCollection 2018.

4.

Chlorhexidine use in adult patients on ICU.

Bouadma L, Karpanen T, Elliott T.

Intensive Care Med. 2018 Dec;44(12):2232-2234. doi: 10.1007/s00134-018-5137-5. Epub 2018 Mar 29. No abstract available.

PMID:
29600393
5.

The risk of microbial contamination associated with six different needle-free connectors.

Casey AL, Karpanen TJ, Nightingale P, Elliott TS.

Br J Nurs. 2018 Jan 25;27(2):S18-S26. doi: 10.12968/bjon.2018.27.2.S18.

PMID:
29368573
6.

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.

Karpanen T, Olweus J.

Front Immunol. 2017 Dec 11;8:1718. doi: 10.3389/fimmu.2017.01718. eCollection 2017. Review.

7.

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.

Jha SK, Rauniyar K, Karpanen T, Leppänen VM, Brouillard P, Vikkula M, Alitalo K, Jeltsch M.

Sci Rep. 2017 Jul 7;7(1):4916. doi: 10.1038/s41598-017-04982-1.

8.

Enhanced chlorhexidine skin penetration with 1,8-cineole.

Casey AL, Karpanen TJ, Conway BR, Worthington T, Nightingale P, Waters R, Elliott TSJ.

BMC Infect Dis. 2017 May 17;17(1):350. doi: 10.1186/s12879-017-2451-4.

9.

An Evolutionarily Conserved Role for Polydom/Svep1 During Lymphatic Vessel Formation.

Karpanen T, Padberg Y, van de Pavert SA, Dierkes C, Morooka N, Peterson-Maduro J, van de Hoek G, Adrian M, Mochizuki N, Sekiguchi K, Kiefer F, Schulte D, Schulte-Merker S.

Circ Res. 2017 Apr 14;120(8):1263-1275. doi: 10.1161/CIRCRESAHA.116.308813. Epub 2017 Feb 8.

10.

Microbiologic contamination of a positive- and a neutral- displacement needleless intravenous access device in clinical use.

Casey AL, Karpanen TJ, Nightingale P, Chaganti S, Elliott TSJ.

Am J Infect Control. 2016 Dec 1;44(12):1678-1680. doi: 10.1016/j.ajic.2016.06.027. Epub 2016 Aug 24.

11.

Addition of PLA2 to CRP enhances sepsis diagnosis.

Elliott TS, Casey AL, Karpanen TJ, David MD, Whitehouse T, Lambert PA, Vernallis AB, Worthington T, Parekh G, Dunston CR, Kirby J, Davis P.

J Infect. 2016 Oct;73(4):386-8. doi: 10.1016/j.jinf.2016.07.009. Epub 2016 Jul 22. No abstract available.

PMID:
27456391
12.

T-cell receptor gene therapy--ready to go viral?

Karpanen T, Olweus J.

Mol Oncol. 2015 Dec;9(10):2019-42. doi: 10.1016/j.molonc.2015.10.006. Epub 2015 Oct 20. Review.

13.

Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.

Karpanen TJ, Casey AL, Whitehouse T, Nightingale P, Das I, Elliott TS.

Am J Infect Control. 2016 Jan 1;44(1):54-60. doi: 10.1016/j.ajic.2015.08.022. Epub 2015 Oct 9.

PMID:
26455868
14.

Antimicrobial activity and skin permeation of iodine present in an iodine-impregnated surgical incise drape.

Casey AL, Karpanen TJ, Nightingale P, Conway BR, Elliott TS.

J Antimicrob Chemother. 2015 Aug;70(8):2255-60. doi: 10.1093/jac/dkv100. Epub 2015 Apr 22.

PMID:
25904727
15.

An in vitro comparison of microbial ingress into 8 different needleless IV access devices.

Casey A, Karpanen T, Nightingale P, Elliott T.

J Infus Nurs. 2015 Jan-Feb;38(1):18-25. doi: 10.1097/NAN.0000000000000082.

PMID:
25545971
16.

CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.

Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Leppänen VM, Holopainen T, Kivelä R, Ortega S, Kärpanen T, Alitalo K.

Circulation. 2014 May 13;129(19):1962-71. doi: 10.1161/CIRCULATIONAHA.113.002779. Epub 2014 Feb 19.

PMID:
24552833
17.

Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis.

Le Guen L, Karpanen T, Schulte D, Harris NC, Koltowska K, Roukens G, Bower NI, van Impel A, Stacker SA, Achen MG, Schulte-Merker S, Hogan BM.

Development. 2014 Mar;141(6):1239-49. doi: 10.1242/dev.100495. Epub 2014 Feb 12.

18.

The zebrafish common cardinal veins develop by a novel mechanism: lumen ensheathment.

Helker CS, Schuermann A, Karpanen T, Zeuschner D, Belting HG, Affolter M, Schulte-Merker S, Herzog W.

Development. 2013 Jul;140(13):2776-86. doi: 10.1242/dev.091876. Epub 2013 May 22.

19.

Reply to Weber and Rutala.

Worthington T, Karpanen T, Casey A, Lambert P, Elliott T.

Infect Control Hosp Epidemiol. 2012 Jun;33(6):645-6. doi: 10.1086/665719. No abstract available.

PMID:
22561728
20.

Microbiological comparison of a silver-coated and a non-coated needleless intravascular connector in clinical use.

Casey AL, Karpanen TJ, Nightingale P, Cook M, Elliott TS.

J Hosp Infect. 2012 Apr;80(4):299-303. doi: 10.1016/j.jhin.2012.01.005. Epub 2012 Feb 17.

PMID:
22341495

Supplemental Content

Loading ...
Support Center